Do Learning Disabilities Affect Testicular Cancer Survival: A National Cohort Study Between 2001 and 2015.


Journal

European urology oncology
ISSN: 2588-9311
Titre abrégé: Eur Urol Oncol
Pays: Netherlands
ID NLM: 101724904

Informations de publication

Date de publication:
12 2020
Historique:
received: 04 10 2018
revised: 09 11 2018
accepted: 12 12 2018
pubmed: 15 8 2019
medline: 29 6 2021
entrez: 15 8 2019
Statut: ppublish

Résumé

Some 1.5 million people in the UK have a learning disability (LD). This vulnerable group derives less benefit from population-based education programs. They are prone to underenrolment in screening programs and may lack the ability to perform self-examination. To identify patients with LD in England and assess their testicular cancer (TC) survival in comparison to the general population. Patient records were identified from the Hospital Episode Statistics database. All patients resident in England with a diagnosis of mental debility, "developmental disorder of scholastic skills", or attending under the specialty of LD between April 1, 2001 and June 30, 2015 were included. We measured survival outcomes according to the Kaplan-Meier method and used log-rank tests to assess survival difference between demographic groups. Of 158138 male patients with LD, 331 had TC and 32 died of cancer. LD patients had a poorer prognosis, with 10-yr TC-specific survival of 88.4% (95% confidence interval [CI] 84.5-92.4%) in the LD group versus 96.8% (95% CI 96.6-97.1%) in the non-LD group. LD patients also had lower all-cause survival rates. The 10-yr survival rate was 77.6% (95% CI 72.2-83.3%) for LD patients versus 89.9% (95% CI 89.4-90.3%) for non-LD patients, while the corresponding 5-yr rates were 84% (95% CI 79.9-88.4%) versus 92.2% (95% CI 91.8-92.5%). Education regarding self-examination for TC must be provided in a format suitable for those with LD. Carers for male patients with LD should be informed about testicular examination and sinister signs. Testicular cancer patients who also have a learning disability (LD) have a one in nine chance of dying, compared to a one in 36 chance for testicular cancer patients without LD. This is because patients with LD are less likely to detect the disease at an earlier stage.

Sections du résumé

BACKGROUND
Some 1.5 million people in the UK have a learning disability (LD). This vulnerable group derives less benefit from population-based education programs. They are prone to underenrolment in screening programs and may lack the ability to perform self-examination.
OBJECTIVE
To identify patients with LD in England and assess their testicular cancer (TC) survival in comparison to the general population.
DESIGN, SETTING, AND PARTICIPANTS
Patient records were identified from the Hospital Episode Statistics database. All patients resident in England with a diagnosis of mental debility, "developmental disorder of scholastic skills", or attending under the specialty of LD between April 1, 2001 and June 30, 2015 were included.
OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS
We measured survival outcomes according to the Kaplan-Meier method and used log-rank tests to assess survival difference between demographic groups.
RESULTS AND LIMITATIONS
Of 158138 male patients with LD, 331 had TC and 32 died of cancer. LD patients had a poorer prognosis, with 10-yr TC-specific survival of 88.4% (95% confidence interval [CI] 84.5-92.4%) in the LD group versus 96.8% (95% CI 96.6-97.1%) in the non-LD group. LD patients also had lower all-cause survival rates. The 10-yr survival rate was 77.6% (95% CI 72.2-83.3%) for LD patients versus 89.9% (95% CI 89.4-90.3%) for non-LD patients, while the corresponding 5-yr rates were 84% (95% CI 79.9-88.4%) versus 92.2% (95% CI 91.8-92.5%).
CONCLUSIONS
Education regarding self-examination for TC must be provided in a format suitable for those with LD. Carers for male patients with LD should be informed about testicular examination and sinister signs.
PATIENT SUMMARY
Testicular cancer patients who also have a learning disability (LD) have a one in nine chance of dying, compared to a one in 36 chance for testicular cancer patients without LD. This is because patients with LD are less likely to detect the disease at an earlier stage.

Identifiants

pubmed: 31411979
pii: S2588-9311(18)30216-5
doi: 10.1016/j.euo.2018.12.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

773-779

Informations de copyright

Copyright © 2018. Published by Elsevier B.V.

Auteurs

Mehran Afshar (M)

St George's University Hospitals NHS Foundation Trust, London, UK.

Hiten R H Patel (HRH)

Department of Urology, North Norway University Hospital, Tromso, Norway.

Maria De-Santis (M)

Cancer Research Unit, University of Warwick, Coventry, UK; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Jamie-Rae Tanner (JR)

University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Tess O'Neill (T)

St George's University Hospitals NHS Foundation Trust, London, UK.

Felicity Evison (F)

University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Nicholas D James (ND)

Cancer Research Unit, University of Warwick, Coventry, UK; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Peter J Selby (PJ)

Leeds Institute of Cancer & Pathology, University of Leeds, Leeds, UK.

Prashant Patel (P)

University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; School of Cancer Sciences, University of Birmingham, Birmingham, UK. Electronic address: p.patel@bham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH